March 18, 2013
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Healio Minute Monday, March 18, 2013 Edition: One drug breaks through, earliest HIV treatment shows gains, deeper colonoscopy sedation carries risk
What just happened in medicine and why do you care?
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Novartis lung cancer drug joins FDA’s ‘breakthrough’ club
Healio.com/Hematology-Oncology: Approval gives experimental drug LDK378 speedier inside track for possible approval to treat ALK-positive NSCLC. Read more.
Antiretroviral therapy for HIV: It’s all about timing and duration
Healio.com/Infectious Disease: Patients treated soonest, longest experience long-term infection control after treatment discontinued. Read more.
Colonoscopies: Deeper sedation heightens certain risks
Healio.com/Gastroenterology: Post-procedure complication risk found higher for patients who received propofol, or anesthesia assistance. Read more.
Upon further review … weight gain adds no CVD risk for ex-smokers
Healio.com/Endocrinology: An extra 5 to 10 pounds has “negligible” effect, contrary to earlier assessments. Read more.
After pregnancy, many adolescents don’t return to primary care
Healio.com/Pediatrics: But one analysis shows that primary care setting provides a “haven” of care and knowledge. Read more.